BAUMFORTH K.R.N. ET AL.: 'Expression of the Epstein-Barr Virus-Encoded Epstein-Barr Virus Nuclear Antigen 1 in Hodgkin's Lymphoma Cells Mediates Up-Regulation of CCL20 and the Migration of Regulatory T Cells.' THE AMERICAN JOURNAL OF PATHOLOGY vol. 173, no. 1, 31 July 2008, pages 195 - 204, XP055388472 (B1)

WO-A2-2012/149416 (B1)

CHANG K.-P. ET AL.: 'Multiplexed Immunobead-Based Profiling Of Cytokine Markers For Detection Of Nasopharyngeal Carcinoma And Prognosis Of Patient Survival.' HEAD & NECK vol. 33, no. 6, 29 November 2010, pages 886 - 897, XP055388437 (B1)

CHANG W.-J. ET AL.: 'Inflammation-related factors predicting prognosis of gastric cancer.' WORLD JOURNAL OF GASTROENTEROLOGY vol. 20, no. 16, 28 April 2014, pages 4586 - 4596, XP055388463 (B1)

CHIA W.-K. ET AL.: 'Adoptive T- cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma.' MOLECULAR THERAPY vol. 22, no. 1, 17 October 2013, pages 132 - 139, XP055329241 (B1)

COMOLI P. ET AL.: 'Cell Therapy of Stage IV Nasopharyngeal Carcinoma With Autologous Epstein-Barr Virus-Targeted Cytotoxic T Lymphocytes.' JOURNAL OF CLINICAL ONCOLOGY vol. 23, no. 35, 03 October 2005, pages 8942 - 8949, XP055075807 (B1)

LAU K.-M. ET AL.: 'Increase in circulating Foxp3+ CD 4+ CD 25high regulatory T cells in nasopharyngeal carcinoma patients.' BRITISH JOURNAL OF CANCER vol. 96, no. 4, 30 January 2007, pages 617 - 622, XP055388458 (B1)

LI J. ET AL.: 'Immunophenotyping at the Time of Diagnosis Distinguishes Two Groups of Nasopharyngeal Carcinoma Patients: Implications for Adoptive Immunotherapy.' INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES vol. 7, no. 5, 18 May 2011, pages 607 - 617, XP055388435 (B1)

LOUIS C.U. ET AL.: 'Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD 45 monoclonal antibodies in NPC patients.' BLOOD vol. 113, no. 11, 29 October 2009, pages 2442 - 2450, XP002717845 (B1)

SPYRIDONIDIS ALEXANDROS ET AL: "Improved Strategy for Rapid Generation of Quadrivirus-Specific CD8+and CD4+Cytotoxic T Lymphocytes (CTLs) for Adoptive Transfer After Stem Cell Transplantation (SCT)", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 120, no. 21, 1 December 2012 (2012-12-01), XP009188963, ISSN: 0006-4971 (B1)

TOH H.C. ET AL.: 'Personalised medicine in nasopharyngeal cancer.' LANCELET ONCOLOGY vol. 13, no. 6, 03 May 2012, pages 568 - 569, XP055388446 (B1)

US-B2- 8 541 185 (B1)

WANG M. ET AL.: 'CURRENT ADVANCES IN T-CELL -BASED CANCER IMMUNOTHERAPY' IMMUNOTHERAPY vol. 6, no. 12, 01 December 2014, pages 1265 - 1278, XP055374102 DOI: 10.2217/IMT.14.86 (B1)

WEIYI PENG ET AL: "PD-1 Blockade Enhances T-cell Migration to Tumors by Elevating IFN-gamma Inducible Chemokines", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 72, no. 20, 1 October 2012 (2012-10-01), pages 5209-5218, XP002729473, ISSN: 0008-5472, DOI: 10.1158/0008-5472.CAN-12-1187 [retrieved on 2012-08-20] (B1)

WO-A1-2007/045996 (B1)

WO-A1-2015/043614 (B1)

WO-A1-2016/057705 (B1)

CAI Y. ET AL.: 'Increased Serum Levels of Macrophage Inflammatory Protein-3a and Cystatin A Predict a Poor Prognosis of Nasopharyngeal Carcinoma.' MEDICINE vol. 93, no. 22, 01 November 2014, pages 1 - 7, XP055495947 DOI: 10.1097/MD.0000000000000123 (B1)